Quick Answer
NEOGENOMICS INC reported Research And Development Expense of $37.08 million for the year ending 2025.
- NEOGENOMICS INC showed an increase of +19.0% in Research And Development Expense from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), NEOGENOMICS INC's Research And Development Expense has grown by 6,728.2%.
- Historical annual values: Fiscal year 2025: $37.08 million | Fiscal year 2024: $31.16 million | Fiscal year 2023: $27.31 million | Fiscal year 2022: $30.33 million | Fiscal year 2021: $21.87 million | Fiscal year 2020: $8.23 million | Fiscal year 2019: $8.49 million | Fiscal year 2018: $3.00 million | Fiscal year 2017: $3.64 million | Fiscal year 2016: $4.65 million | Fiscal year 2015: $4.20 million | Fiscal year 2014: $2.69 million | Fiscal year 2013: $2.44 million | Fiscal year 2012: $2.28 million | Fiscal year 2011: $543.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: